+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Monitoring, Treatment and Drug Delivery Market | US | 2019-2025

  • PDF Icon

    Report

  • June 2019
  • Region: United States
  • iData Research
  • ID: 4876624
Description Jump to:
The fastest-growing segment in the U.S. diabetes market is the FGM market, which has increased dramatically in value. The high level of growth was attributed to the commercial launch of FGM. Abbott received FDA approval for FreeStyle® Libre and for FreeStyle® Libre 14 Day. The FGM market has experienced significant growth in international markets since it was first commercially launched in Europe almost ten years ago. Growth in the U.S. market is expected to follow a similar trend, primarily attributed to an expanding installed base of FGM users.

The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes and insulin pumps.

Table of Contents

TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTS
1. EXECUTIVE SUMMARY
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
3. U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
3.1 MARKET OVERVIEW
3.2 TREND ANALYSIS BY SEGMENT
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
3.5 MERGERS AND ACQUISITIONS
4. PATIENT DEMOGRAPHICS
4.1 PATIENT DEMOGRAPHICS
4.1.1 Diagnosed Diabetic Population by Type
4.1.2 Diagnosed Type 2 Diabetic Population by Type
4.1.3 Diagnosed Insulin-Dependent Diabetic Population by Type
4.2 INSTALLED BASE ANALYSIS AND FORECAST
4.2.1 Personal Glucose Monitoring Installed Base by Segment
4.2.2 Personal CGM Installed Base by Insulin Therapy
4.2.3 Insulin User Installed Base by Segment
4.2.4 Durable Pump Installed Base by Diabetes Type
4.2.5 Patch Pump Installed Base by Diabetes Type
4.2.6 MDI Installed Base by Segment
4.2.7 MDI Installed Base by Diabetes Type
5. BLOOD GLUCOSE METER MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Personal Blood Glucose Meter Market
5.3.2 Professional Blood Glucose Meter Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS
6. BLOOD GLUCOSE TEST STRIP MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Personal Blood Glucose Test Strip Market
6.3.1.1 Medicare/Medicaid Blood Glucose Test Strip Market
6.3.1.2 Managed Care Blood Glucose Test Strip Market
6.3.1.3 Cash Blood Glucose Test Strip Market
6.3.2 Professional Blood Glucose Test Strip Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS
7. LANCET MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Personal Lancet Market
7.3.2 Professional Lancet Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
8. CONTINUOUS GLUCOSE MONITORING MARKET
8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Personal Continuous Glucose Monitoring Market
8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
8.3.2 Total Professional Continuous Glucose Monitoring Market
8.3.2.1 Professional Continuous Glucose Monitoring System Market
8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
8.5.1 Continuous Glucose Monitoring Market
8.5.2 Continuous Glucose Monitoring Market Installed Base Share
9. FLASH GLUCOSE MONITORING MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Flash Glucose Monitoring Reader Market
9.3.2 Flash Glucose Monitoring Sensor Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
10. INSULIN MARKET
10.1 INTRODUCTION
10.1.1 Insulin Types
10.1.1.1 Rapid-Acting Insulin Analog
10.1.1.2 Regular Human Insulin
10.1.1.3 Intermediate-Acting Human Insulin
10.1.1.4 Long-Acting Insulin Analog
10.1.1.5 Ultra-Long-Acting Insulin Analog
10.1.1.6 Premixed Insulin
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Insulin Market
10.3.2 Long-Acting Insulin Market
10.3.3 Ultra-Long-Acting Insulin Market
10.3.4 Rapid-Acting Insulin Market
10.3.5 Premixed Insulin Market
10.3.6 Human Insulin Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
11. INSULIN PEN MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Reusable Pen Market
11.3.2 Total Pen Needle Market
11.3.2.1 Conventional Pen Needle Market
11.3.2.2 Safety Pen Needle Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
12. INSULIN SYRINGE MARKET
12.1 INTRODUCTION
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Conventional Insulin Syringe Market
12.3.2 Safety Insulin Syringe Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
13. INSULIN PUMP MARKET
13.1 INTRODUCTION
13.1.1 Durable Insulin Pumps
13.1.2 Patch Insulin Pumps
13.1.3 Simple Insulin Pumps
13.2 MARKET OVERVIEW
13.3 INSTALLED BASE OVERVIEW
13.4 MARKET ANALYSIS AND FORECAST
13.4.1 Total Durable Insulin Pump Market
13.4.1.1 Durable Pump Market
13.4.1.2 Infusion Set Market
13.4.1.3 Pump Reservoir Market
13.4.2 Total Patch Insulin Pump Market
13.4.2.1 Patch Pump System Market
13.4.2.2 Insulin Pod Market
13.4.3 Simple Insulin Pump Market
13.5 DRIVERS AND LIMITERS
13.5.1 Market Drivers
13.5.2 Market Limiters
13.6 COMPETITIVE MARKET SHARE ANALYSIS
13.6.1 Insulin Pump Market
13.6.2 Durable Insulin Pump Market
13.6.3 Insulin Pump Market Installed Base Share
13.6.4 Emerging Competitors
14. ABBREVIATIONS

Companies mentioned

  • Abbott
  • ACON Laboratories
  • AgaMatrix
  • Allison Medical
  • ApexBio
  • Arcadia Group
  • ARKRAY
  • Ascensia
  • B. Braun
  • Becton Dickinson
  • Bionime
  • Biosense Medical Devices
  • Boehringer Ingelheim
  • CanAm
  • CVS
  • DarioHealth
  • Dexcom
  • Diabetic Supply of Suncoast
  • Eli Lilly
  • Excel International
  • Fifty 50 Medical
  • ForaCare
  • Genesis Health Technologies
  • Gluco Perfect
  • Home Aide Diagnostics
  • iHealth Labs
  • Infopia
  • Insulet
  • Intuity Medical
  • i-SENS
  • LifeScan
  • Livongo Health
  • McKesson
  • Medical Plastic Devices
  • MediPurpose
  • Medline
  • Medtronic
  • Nova Biomedical
  • Novo Nordisk
  • Oak Tree Health
  • Omnis Health
  • One Drop
  • Owen Mumford
  • Perrigo
  • Pharma Supply
  • Philosys
  • Platinum Equity
  • Playtex
  • Prodigy
  • Retractable Technologies
  • Roche
  • Sanofi
  • SD Biosensor
  • Senseonics
  • Simple Diagnostics
  • Smart Meter
  • Smiths Medical
  • Specialty Medical Supplies
  • STAT Medical Devices
  • Tandem
  • Telcare
  • Terumo
  • Trivia Health
  • U.S. Diagnostics
  • UltiMed
  • Unilife Medical Solutions
  • Valeritas
  • Vertex Diagnostics
  • Walmart
  • Ypsomed

Related Topics

Related Reports

Global Glucose Monitoring Devices Market by Type (Diabetes Monitoring Devices, Insulin Delivery Devices), Application (Gestational Diabetes, Type 1 Diabetes, Type 2 Diabetes), End-User - Forecast 2024-2030 - Product Image

Global Glucose Monitoring Devices Market by Type (Diabetes Monitoring Devices, Insulin Delivery Devices), Application (Gestational Diabetes, Type 1 Diabetes, Type 2 Diabetes), End-User - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 236 Pages
  • Global
From
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 80 Pages
  • Australia, New Zealand Australia, New Zealand
From
Global Diabetes Devices and Therapeutics Business Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update - Product Image

Global Diabetes Devices and Therapeutics Business Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

  • Report
  • 1300 Pages
  • Global
From
Germany Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update - Product Image

Germany Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update

  • Report
  • 51 Pages
  • Germany
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.